SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense trading activity as market participants speculate on a potential acquisition by major tech players like Amazon, following reports of ongoing buyout talks that have triggered a massive surge in volume. The community is actively debating the implications of this possible deal, contrasting the potential buyout premium against current market valuations while weighing the company's critical role in satellite connectivity and its long-standing partnership with Apple.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is in the spotlight as investors anticipate the upcoming Artemis II mission, which marks the first crewed deep-space flight in over 50 years. The community is actively debating the stock's long-term potential within the lunar economy while closely monitoring technical price levels and market-wide volatility driven by geopolitical tensions.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is capturing significant investor interest as the community reacts to a confirmed launch window for the BlueBird-7 satellite, serving as a critical catalyst after recent price volatility. Discussions are heavily focused on the stock's long-term infrastructure potential versus the risks of execution delays, with investors debating whether to treat recent pullbacks as prime accumulation opportunities ahead of broader sector growth.

nCino, Inc. engages in the provision of cloud-based software applications for financial institutions in the United States and internationally. Its nCino Bank Operating System, a tenant cloud platform, digitizes, automates, and streamlines complex processes and workflow, and utilizes data analytics and artificial intelligence and machine learning (AI/ML) to enable financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposit and other accounts, and manage regulatory compliance. The firm's nCino IQ is an application suite that utilizes data analytics and AI/ML to provide its customers with automation and insights into their operations, such as tools for analyzing, measuring, and managing credit risk, as well as to enhance their ability to comply with regulatory requirements. The company was founded by Pierre Naudé in 2011 and is headquartered in Wilmington, NC.

Ncino Inc.

nCino is currently in focus following a significant expansion of its stock repurchase program, which has fueled positive community sentiment regarding the company's long-term capital allocation strategy. Investors and analysts are actively debating the stock's valuation after strong earnings performance and management's focus on accelerating growth in its cloud banking and AI-driven product offerings.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to the company moving up its earnings report to April 1st, fueling intense speculation about potential surprises or major catalysts. The community remains deeply divided, with bulls highlighting beverage expansion deals and upcoming federal CBD Medicare pilot programs, while vocal critics continue to focus on long-standing frustrations regarding share dilution, leadership, and sector-wide volatility.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining attention as investors digest new contract awards and the company's expanding role in national security and NASA lunar missions. The community is actively debating the impact of ongoing insider selling by private equity firms against the stock's long-term potential in the growing space and defense sectors.

Launchr is a programmable creator fee engine designed to adapt to every stage of a token’s lifecycle.  Instead of hard coded splits or one time choices, Launchr lets creators dynamically route fees in real time based on market conditions, liquidity depth, and strategy.

Launchr

LAUNCHR is generating significant buzz following its recent debut as investors debate the sustainability of the project amidst a broader landscape of speculative, short-term crypto assets.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is currently at the center of a tug-of-war between retail traders anticipating a turnaroundfueled by speculation of increased institutional involvement, potential short squeeze setups, and seasonal travel tailwindsand skeptics highlighting significant debt and earnings volatility. The community remains heavily focused on monitoring call flow and technical indicators, with intense debate over whether current price levels offer a deep-value opportunity or if the stock remains trapped by structural headwinds.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened volatility as retail traders speculate on a potential short squeeze, frequently comparing its low float and share structure to past parabolic meme stock runs. While some community members anticipate a massive rally based on historical spikes, others warn of significant downside risk, characterizing the activity as a high-stakes pump and dump involving extreme borrowing fees.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is seeing significant volatility following the announcement that its Phase 2 clinical trial for ALTO-101 failed to meet primary statistical significance. While the stock has faced sharp downward pressure, the community remains divided, with some investors focusing on the company's shift in strategic priorities toward their lead asset, ALTO-207, and others expressing skepticism about the remaining pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian Pharma Billionaires Pile Into Generic Weight-Loss Drugs, Sparking Regulatory Scrutiny

… Dilip Shanghvi’s Sun Pharmaceutical Industries introduced semaglutide pen injections … stepping up scrutiny of the new drugs . “With the recent introduction of … strictures against the promotion of these drugs prohibiting “surrogate advertisements and …

SunPharma’s ‘HeartkeLiye8–Making India Heart Strong’ campaign urges Indians to prioritise heart health through daily actions

As India’s No. 1* pharmaceutical company in the cardio-metabolic therapy, Sun Pharma plays a significant role in addressing the growing burden of cardiovascular diseases,with strong leadership across lipid-lowering therapies and a substantial presence in anti-hypertensive and oral anti-diabetes treatments.

Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances

New Delhi: Sun Pharmaceutical Industries Limited has announced that … immunology portfolio in detail. Sun Pharma emphasized that these presentations reinforce … patient-centered research approaches. Sun Pharmaceutical Industries Limited, headquartered in India …

Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha Khemka

India's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.

GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics

Indian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and Torrent Pharma are identified as potential market leaders. Despite initial stockouts online, companies are adjusting supply. The market for these diabetes and obesity drugs is expected to grow significantly in India.

Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.

Current Price	1,730.90
Prev Close	1,762.00
Open	1,762.10
Dividend Yield	0.92%
50-Day Moving Average	1,722.70
Beta	0.08
Avg. Volume	3.04M
PE Ratio	37.99

52-Week High	1,851.20
52-Week Low	1,548.00
Market Capitalization	4.22T
EPS (Annual)	45.55
Price to Book	5.33
Revenue Per Employee	20.16M

SUNPHARMA.NSE
Sun Pharmaceutical Industries Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SUNPHARMA.NSE News

SUNPHARMA.NSESun Pharmaceutical Industries Ltd.